Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. But what's the best way to find the ...

Corcept (CORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Exceeding their quarterly expectations on Wednesday, here are three top-rated Zacks stocks to consider after posting pleasant ...

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor. But how do you find the right combination of stocks?

Hims & Hers Health, Inc. (HIMS) concluded the recent trading session at $31.86, signifying a +1.01% move from its prior day's close.

Canadian Pacific Kansas City (CP) delivered earnings and revenue surprises of 5.75% and 1.91%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the ...

A unique, proprietary stock-rating model, the Zacks Rank uses earnings estimate revisions, or changes to a company's earnings expectations, to help investors create a winning portfolio.

NextEra (NEE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

The Zacks Rank, which is a unique, proprietary stock-rating model, employs earnings estimate revisions, or changes to a company's earnings expectations, that makes building a winning portfolio easier.

Charles Schwab (SCHW) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.